日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis.

C型利钠肽/环磷酸鸟苷信号在肺纤维化中的病理生理和治疗意义。

Weyer Rene, Völker Katharina, Potapenko Tamara, Krebes Lisa, Abeßer Marco, Friedrich Anna-Lena, Lessmann Eva, Khadim Ali, Ruppert Clemens, El Agha Elie, Sheta Dalia, Beilhack Andreas, Santi Daniel V, Schneider Eric L, Kuhn Michaela, Dabral Swati

Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma.

rucaparib 联合 PLX038A 治疗浆液性子宫内膜癌的抗肿瘤活性

Hou Xiaonan, Zanfagnin Valentina, Xu Conway, Jessen Erik, Liu Yuanhang, Wang Chen, Huang Yajue, Fontaine Shaun D, Santi Daniel V, Colon-Otero Gerardo, Gill Sarah E, Glaser Gretchen E, Butler Kristina A, Bakkum-Gamez Jamie N, Dowdy Sean C, Oberg Ann L, Larson Melissa C, Atkinson Hunter J, Duffield Laura N, Peterson Kevin L, Kaufmann Scott H, Weroha S John

Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer

用于前列腺癌成像和治疗的靶向前列腺特异性膜抗原的星形PEG纳米载体

Meher, Niranjan; Ashley, Gary W; Bobba, Kondapa Naidu; Wadhwa, Anju; Bidkar, Anil P; Dasari, Chandrashekhar; Mu, Changhua; Sankaranarayanan, Ramya Ambur; Serrano, Juan A Camara; Raveendran, Athira; Bulkley, David P; Aggarwal, Rahul; Greenland, Nancy Y; Oskowitz, Adam; Wilson, David M; Seo, Youngho; Santi, Daniel V; VanBrocklin, Henry F; Flavell, Robert R

The limitation of lipidation: Conversion of semaglutide from once-weekly to once-monthly dosing

脂化疗法的局限性:将司美格鲁肽的给药频率从每周一次改为每月一次

Schneider, Eric L; Hangasky, John A; Fernández, Rocío Del Valle; Ashley, Gary W; Santi, Daniel V

Could a Long-Acting Prodrug of SN-38 be Efficacious in Sacituzumab Govitecan-Resistant Tumors?

SN-38 的长效前药能否对 Sacituzumab Govitecan 耐药肿瘤有效?

Santi, Daniel V; Ashley, Gary W; Cabel, Luc; Bidard, Francois-Clement

PLX038A, a long-acting SN-38, penetrates the blood-tumor-brain-barrier, accumulates and releases SN-38 in brain tumors to increase survival of tumor bearing mice

PLX038A 是一种长效 SN-38,它能穿透血脑屏障,在脑肿瘤中积累并释放 SN-38,从而提高荷瘤小鼠的存活率。

Jung, Jinkyu; Schneider, Eric L; Zhang, Wei; Song, Hua; Zhang, Meili; Chou, William; Meher, Niranjan; VanBrocklin, Henry F; Barcellos-Hoff, Mary Helen; Ozawa, Tomoko; Gilbert, Mark R; Santi, Daniel V

A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors

长效依沙替康及其与DNA损伤反应抑制剂的协同作用

Fontaine, Shaun D; Carreras, Christopher W; Reid, Ralph R; Ashley, Gary W; Santi, Daniel V

PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM-Deficient Tumors and Potent Synergy With PARP Inhibitors

PLX038:一种长效拓扑异构酶 I 抑制剂,对 ATM 缺陷型肿瘤具有强大的抗肿瘤活性,并与 PARP 抑制剂具有显著的协同作用

Thomas, Anish; Fontaine, Shaun D; Diolaiti, Morgan E; Desai, Parth; Kumar, Rajesh; Takahashi, Nobuyuki; Sciuto, Linda; Nichols, Samantha; Ashworth, Alan; Feng, Felix Y; Ashley, Gary W; Nguyen, Minh; Pommier, Yves; Santi, Daniel V

Does sacituzumab-govitecan act as a conventional antibody drug conjugate (ADC), a prodrug of SN-38 or both?

sacituzumab-govitecan 的作用机制是作为常规抗体药物偶联物 (ADC)、SN-38 的前药,还是两者兼具?

Santi, Daniel V; Cabel, Luc; Bidard, François-Clément

Interleukin 15 Pharmacokinetics and Consumption by a Dynamic Cytokine Sink

白细胞介素 15 的药代动力学及其在动态细胞因子池中的消耗

Hangasky, John A; Waldmann, Thomas A; Santi, Daniel V